CDKN1B and neoplasm: Finally, to explore the possible mechanisms underlying the diverse phenotypes we analyzed the impact that a possible senescent checkpoint might have in the tumor promotion inhibition observed, we crossed these lines to p53(+/−) heterozygous mice, to mammary specific p53(R172H) mutant expression, and to p27 knock-out mice.